H Yamamoto, H Okamoto. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adenoma, Islet Cell/drug therapyAnimalsBenzamides/pharmacologyCell LineCell Survival/drug effectsCricetinaeDNA Repair/drug effectsInsulinoma/drug therapyIslets of Langerhans/enzymologyMesocricetusNAD+ Nucleosidase/antagonists & inhibitorsNeoplasms, Experimental/drug therapyNiacinamide/pharmacologyPancreatic Neoplasms/drug therapyPoly(ADP-ribose) Polymerase InhibitorsRatsStreptozocin/pharmacology
Substances: See more » BenzamidesPoly(ADP-ribose) Polymerase InhibitorsNiacinamideStreptozocin3-aminobenzamideNAD+ Nucleosidase
Year: 1982 PMID: 6290270 DOI: 10.1016/0014-5793(82)80187-7
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124